USD10
SRPT Shares
About Sarepta TherapeuticsSarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
USD10
SRPT Shares
About Sarepta TherapeuticsSarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
Stats
TRADING WINDOW
Closed
OPENS AT
Mar 27 at 1:30 PM GMT+0
MARKET CAP
$2.31B
OPEN PRICE
Not enough data
LOW (1Y)
$10.42
HIGH (1Y)
$72.05
LOW (24H)
$21.37
HIGH (24H)
$23.49
VOLUME (24H)
$2.63K
99.97%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $23.37 | |
1 Week | $16.65 | |
1 Month | $17.11 | |
1 Year | $70.41 |